Why ODs should care about antibiotic resistance

Article

Milton Hom, OD, FAAO, shares why optometrists should care about antibiotic resistance.

 

 

 

Milton Hom, OD, FAAO, shares why optometrists should care about antibiotic resistance. This video is the second in a series on antibiotic resistance.

Click here to check out the first video from Kathy Mastrota, MS, OD, FAAO.

 

Want to learn more?

Check out our Antibiotic Resistance Resource Center

Related: Dr. Kathy Mastrota explains antibiotic resistance

Related: Oral antibiotics not effective in MGD?

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Related Content
Qlaris Bio announces development of QLS-111-FDC ©Luqman Aditiamala—stock.adobe.com

Qlaris Bio announces development of QLS-111-FDC

Kassi Filkins, Editor
June 13th 2025
Article
New Opportunities in Topical Glaucoma Management

New Opportunities in Topical Glaucoma Management

Mitch Ibach, OD, FAAO;Jessica Steen, OD, FAAO
January 31st 2025
Podcast
FDA approves Amneal formulation of prednisolone acetate ophthalmic solution 1% - Image credit: ©KMPZZZ—stock.adobe.com

FDA approves Amneal formulation of prednisolone acetate ophthalmic solution 1%

Emily Kaiser Maharjan, Assistant Managing Editor;Martin David Harp, Editor, Ophthalmology Times
June 12th 2025
Article
You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO

You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO

Miriam Korik, OD;Tiffany Tsoi, OD;Emily Kaiser Maharjan, Assistant Managing Editor
December 4th 2024
Podcast
US Capitol building Image credit: AdobeStock/Sheik

VBM reform efforts continue with latest bill introduction

Jordana Joy, Associate Editor
June 12th 2025
Article
Visual field test and OCT images on table Image credit: AdobeStock/izzuan

Taking your OCT outside of the posterior pole

Jim Williamson, OD, FAAO, FORS
June 12th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.